At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
Oxytocin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Oxytocin on Fear Memory Consolidation: A Novel Intervention to Prevent PTSD
In Brief
A clinical study evaluating Oxytocin and Placebo for Posttraumatic Stress Disorder. Completed, enrolled 60 participants across 1 site.
Detailed Summary
The purpose of the study is to learn how differences in learning under mildly-stressful circumstances may be changed by taking oxytocin. Oxytocin is a hormone made naturally in the body. The investigators will also examine the impact of any anxiety, depression, and stress related symptoms on learning processes.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPosttraumatic Stress Disorder
CountriesUnited States
CollaboratorsUnited States Department of Defense
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2011
First PostedNov 2011
Primary CompletionMay 2014
TodayJul 2026
First PostedNov 7, 2011
Enrollment StartOct 1, 2011
Primary CompletionMay 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 14.7 years ago
Interventions
Oxytocindrug
Liquid metered-dose nasal spray, 30 IUs, administered once.
Placebodrug
Matched nasal spray placebo